Colinz Labs

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE923C01011
NSEID:
BSEID: 531210

INR

42.26

0.26 (0.62%)

BSENSE

Dec 05

BSE+NSE Vol: 972

{
  "main_header": {
    "sid": 621096,
    "name": "Colinz Labs",
    "stock_name": "Colinz Labs",
    "full_name": "Colinz Laboratories Ltd",
    "name_url": "stocks-analysis/colinz-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "42.26",
    "chg": 0.26,
    "chgp": "0.62%",
    "dir": 1,
    "prev_price": "42.00",
    "mcapval": "19.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531210,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE923C01011",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "972 ",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/colinz-labs-621096-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Colinz Labs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-colinz-labs-fallingrising-3729712",
        "imagepath": "",
        "date": "2025-11-26 00:46:59",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Colinz Laboratories opened the trading session with a gap down of 5.93%, signalling immediate selling pressure from the outset. Despite an intraday high of ₹43.39, representing a modest 3.26% gain from the previous close, the stock ultimately succumbed to bearish momentum, touching a low of ₹39.53 before settling near that level. The weighted average price indicates that a greater volume of shares exchanged hands closer to the day's low, underscoring the dominance of sellers throughout the session.</p>\n<p>The stock has been on a downward trajectory for the past three consecutive days, cumulatively losing 7.11% in that span. This short-term weakness is compounded by the fact that Colinz Laboratories has underperformed its sector by 5.2%..."
      },
      {
        "title": "Why is Colinz Labs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-colinz-labs-fallingrising-3702316",
        "imagepath": "",
        "date": "2025-11-14 21:44:17",
        "description": "As of 14-Nov, Colinz Laboratories Ltd is experiencing a price increase, currently at 42.74, which reflects a rise of 0.94 or 2.25%. The stock has shown strong performance recently, gaining for four consecutive days and achieving a total return of 7.49% during this period. Additionally, it has outperformed its sector by 1.88%. In terms of returns compared to the benchmark, over the past week, the stock has increased by 2.91%, while the Sensex has risen by 1.62%. The stock's delivery volume has also seen a significant increase of 48.13% compared to the five-day average, indicating rising investor participation. However, it is important to note that there is no information available regarding any positive or negative factors that could further explain the stock's recent movement.\n\nBroader Market Context: In the short term, Colinz Laboratories Ltd has outperformed the Sensex, which suggests that investor sentim..."
      },
      {
        "title": "Colinz Laboratories Hits New 52-Week Low at Rs. 36.11",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-hits-new-52-week-low-at-rs-3611-3696966",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ColinzLaborator_priceRelatedfactors_3696966.png",
        "date": "2025-11-13 09:58:38",
        "description": "Colinz Laboratories has reached a new 52-week low of Rs. 36.11, reflecting a year-to-date decline of 32.98%. Despite recent gains over three days, the company faces challenges such as weak long-term fundamentals and low return on equity, while the broader market shows mixed performance."
      },
      {
        "title": "Colinz Laboratories Hits New 52-Week Low at Rs. 37.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-hits-new-52-week-low-at-rs-374-3689984",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ColinzLaborator_priceRelatedfactors_3689984.png",
        "date": "2025-11-11 14:13:49",
        "description": "Colinz Laboratories has reached a new 52-week low, reflecting a significant downturn in its stock performance. The company has underperformed its sector and experienced a notable decline over the past year, with weak financial metrics contributing to its challenges in the market."
      },
      {
        "title": "Why is Colinz Labs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-colinz-labs-fallingrising-3676571",
        "imagepath": "",
        "date": "2025-11-06 21:25:46",
        "description": "As of 06-Nov, Colinz Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 39.81, which represents a decrease of 4.42 or 9.99%. The stock has underperformed its sector by 9.22% today and has opened with a loss of 4.07%. It has touched an intraday low of Rs 39.81, indicating significant selling pressure. The stock has also fallen after two consecutive days of gains, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable drop in investor participation, with delivery volume falling by 77.12% against the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, Colinz Laboratories Ltd's performance over the past week shows a decline of 9.48%, while the benchmark Sensex has only decrea..."
      },
      {
        "title": "Colinz Laboratories Ltd Faces 9.99% Decline Amid Significant Selling Pressure and Ongoing Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-ltd-faces-999-decline-amid-significant-selling-pressure-and-ongoing-losses-3675987",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ColinzLaborator_only_sellers_3675987.png",
        "date": "2025-11-06 14:35:28",
        "description": "Colinz Laboratories Ltd is experiencing substantial selling pressure, with its stock declining significantly over various time frames. The company has faced consecutive losses, underperforming against the Sensex and its sector. Factors contributing to this trend include trading below key moving averages and ongoing challenges in its market position."
      },
      {
        "title": "Are Colinz Labs latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-colinz-labs-latest-results-good-or-bad-3671639",
        "imagepath": "",
        "date": "2025-11-04 19:45:34",
        "description": "Colinz Laboratories' latest financial results for Q2 FY26 reveal a complex operational landscape characterized by significant challenges. The company reported net sales of ₹1.39 crores, reflecting a decline of 11.46% from the previous quarter and a more pronounced year-on-year decrease of 25.27%. This trend indicates ongoing difficulties in maintaining revenue momentum, as the company has now experienced negative growth in sales for several consecutive quarters.\n\nDespite the revenue decline, Colinz Laboratories reported a net profit of ₹0.14 crores, which represents a sequential improvement of 16.67% compared to the previous quarter. However, this figure is down 12.50% year-on-year, suggesting that while there may be some short-term resilience in net profit, the overall financial health remains under pressure due to the declining top-line performance.\n\nOperating margins also faced significant compression, w..."
      },
      {
        "title": "Is Colinz Labs overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-colinz-labs-overvalued-or-undervalued-3668665",
        "imagepath": "",
        "date": "2025-11-04 08:06:53",
        "description": "As of 3 November 2025, Colinz Labs has moved from a fair to an expensive valuation grade. The company is currently overvalued, with a PE ratio of 42.76, an EV to EBIT of 15.61, and a ROE of 5.07%. In comparison to its peers, Sun Pharma has a PE of 35.62 and an EV to EBITDA of 24.18, while Cipla shows a more attractive PE of 22.44 and an EV to EBITDA of 5.66, highlighting Colinz Labs' relatively high valuation metrics.\n\nDespite a recent uptick in stock price, with a 1-week return of 3.46% compared to a -0.94% return on the Sensex, the overall performance year-to-date shows a decline of 35.64% against a 7.47% increase in the Sensex. This suggests that while there may be short-term gains, the long-term outlook for Colinz Labs remains concerning given its current overvaluation in the context of its peers...."
      },
      {
        "title": "How has been the historical performance of Colinz Labs?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-colinz-labs-3667925",
        "imagepath": "",
        "date": "2025-11-03 22:43:16",
        "description": "Answer:\nThe historical performance of Colinz Labs shows a fluctuating trend in net sales and profits over the years, with a slight decline in recent periods.\n\nBreakdown:\nColinz Labs reported net sales of 6.53 Cr in March 2025, down from 7.03 Cr in March 2024 and 7.15 Cr in March 2023, indicating a downward trend in revenue. The total operating income mirrored this decline, remaining at 6.53 Cr in March 2025. The company's total expenditure, excluding depreciation, decreased to 6.03 Cr in March 2025 from 6.49 Cr in March 2024. Operating profit (PBDIT) was 0.80 Cr in March 2025, slightly lower than 0.82 Cr in March 2024, while profit before tax was 0.62 Cr, down from 0.65 Cr the previous year. Profit after tax showed a modest increase to 0.50 Cr in March 2025 from 0.49 Cr in March 2024. The company's total assets rose to 11.82 Cr in March 2025 from 11.36 Cr in March 2024, and total liabilities also increased ..."
      }
    ],
    "total": 590,
    "sid": "621096",
    "stock_news_url": "https://www.marketsmojo.com/news/colinz-laboratories-621096"
  },
  "announcements": [
    {
      "caption": "REVISED Outcome Of The Board Meeting",
      "datetime": "27-Nov-2025",
      "details": "Dear Sir Please find the attached REVISED OURCOME OF THE MEETING held on 27-11-2025. Kindly take the note of the same. Director",
      "source": "BSE"
    },
    {
      "caption": "Appointment of Company Secretary and Compliance Officer",
      "datetime": "27-Nov-2025",
      "details": "Dear Sir Please find the attached below the appointment of Company Secretary and Compliance Officer with effect form 1-12-2025. Kindly update the same at your end and oblige us. Director",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of The Board Meeting",
      "datetime": "27-Nov-2025",
      "details": "Dear I have submitted the Outcome of Board meeting held on 27-11-2025 without sign hence submitting it again with signature. Kindly consider the same. Director",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Colinz Labs falling/rising?

2025-11-26 00:46:59

Recent Price Movement and Market Context

Colinz Laboratories opened the trading session with a gap down of 5.93%, signalling immediate selling pressure from the outset. Despite an intraday high of ₹43.39, representing a modest 3.26% gain from the previous close, the stock ultimately succumbed to bearish momentum, touching a low of ₹39.53 before settling near that level. The weighted average price indicates that a greater volume of shares exchanged hands closer to the day's low, underscoring the dominance of sellers throughout the session.

The stock has been on a downward trajectory for the past three consecutive days, cumulatively losing 7.11% in that span. This short-term weakness is compounded by the fact that Colinz Laboratories has underperformed its sector by 5.2%...

Why is Colinz Labs falling/rising?

2025-11-14 21:44:17

As of 14-Nov, Colinz Laboratories Ltd is experiencing a price increase, currently at 42.74, which reflects a rise of 0.94 or 2.25%. The stock has shown strong performance recently, gaining for four consecutive days and achieving a total return of 7.49% during this period. Additionally, it has outperformed its sector by 1.88%. In terms of returns compared to the benchmark, over the past week, the stock has increased by 2.91%, while the Sensex has risen by 1.62%. The stock's delivery volume has also seen a significant increase of 48.13% compared to the five-day average, indicating rising investor participation. However, it is important to note that there is no information available regarding any positive or negative factors that could further explain the stock's recent movement. Broader Market Context: In the short term, Colinz Laboratories Ltd has outperformed the Sensex, which suggests that investor sentim...

Colinz Laboratories Hits New 52-Week Low at Rs. 36.11

2025-11-13 09:58:38

Colinz Laboratories has reached a new 52-week low of Rs. 36.11, reflecting a year-to-date decline of 32.98%. Despite recent gains over three days, the company faces challenges such as weak long-term fundamentals and low return on equity, while the broader market shows mixed performance.

Colinz Laboratories Hits New 52-Week Low at Rs. 37.4

2025-11-11 14:13:49

Colinz Laboratories has reached a new 52-week low, reflecting a significant downturn in its stock performance. The company has underperformed its sector and experienced a notable decline over the past year, with weak financial metrics contributing to its challenges in the market.

Why is Colinz Labs falling/rising?

2025-11-06 21:25:46

As of 06-Nov, Colinz Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 39.81, which represents a decrease of 4.42 or 9.99%. The stock has underperformed its sector by 9.22% today and has opened with a loss of 4.07%. It has touched an intraday low of Rs 39.81, indicating significant selling pressure. The stock has also fallen after two consecutive days of gains, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable drop in investor participation, with delivery volume falling by 77.12% against the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, Colinz Laboratories Ltd's performance over the past week shows a decline of 9.48%, while the benchmark Sensex has only decrea...

Colinz Laboratories Ltd Faces 9.99% Decline Amid Significant Selling Pressure and Ongoing Losses

2025-11-06 14:35:28

Colinz Laboratories Ltd is experiencing substantial selling pressure, with its stock declining significantly over various time frames. The company has faced consecutive losses, underperforming against the Sensex and its sector. Factors contributing to this trend include trading below key moving averages and ongoing challenges in its market position.

Are Colinz Labs latest results good or bad?

2025-11-04 19:45:34

Colinz Laboratories' latest financial results for Q2 FY26 reveal a complex operational landscape characterized by significant challenges. The company reported net sales of ₹1.39 crores, reflecting a decline of 11.46% from the previous quarter and a more pronounced year-on-year decrease of 25.27%. This trend indicates ongoing difficulties in maintaining revenue momentum, as the company has now experienced negative growth in sales for several consecutive quarters. Despite the revenue decline, Colinz Laboratories reported a net profit of ₹0.14 crores, which represents a sequential improvement of 16.67% compared to the previous quarter. However, this figure is down 12.50% year-on-year, suggesting that while there may be some short-term resilience in net profit, the overall financial health remains under pressure due to the declining top-line performance. Operating margins also faced significant compression, w...

Is Colinz Labs overvalued or undervalued?

2025-11-04 08:06:53

As of 3 November 2025, Colinz Labs has moved from a fair to an expensive valuation grade. The company is currently overvalued, with a PE ratio of 42.76, an EV to EBIT of 15.61, and a ROE of 5.07%. In comparison to its peers, Sun Pharma has a PE of 35.62 and an EV to EBITDA of 24.18, while Cipla shows a more attractive PE of 22.44 and an EV to EBITDA of 5.66, highlighting Colinz Labs' relatively high valuation metrics. Despite a recent uptick in stock price, with a 1-week return of 3.46% compared to a -0.94% return on the Sensex, the overall performance year-to-date shows a decline of 35.64% against a 7.47% increase in the Sensex. This suggests that while there may be short-term gains, the long-term outlook for Colinz Labs remains concerning given its current overvaluation in the context of its peers....

How has been the historical performance of Colinz Labs?

2025-11-03 22:43:16

Answer: The historical performance of Colinz Labs shows a fluctuating trend in net sales and profits over the years, with a slight decline in recent periods. Breakdown: Colinz Labs reported net sales of 6.53 Cr in March 2025, down from 7.03 Cr in March 2024 and 7.15 Cr in March 2023, indicating a downward trend in revenue. The total operating income mirrored this decline, remaining at 6.53 Cr in March 2025. The company's total expenditure, excluding depreciation, decreased to 6.03 Cr in March 2025 from 6.49 Cr in March 2024. Operating profit (PBDIT) was 0.80 Cr in March 2025, slightly lower than 0.82 Cr in March 2024, while profit before tax was 0.62 Cr, down from 0.65 Cr the previous year. Profit after tax showed a modest increase to 0.50 Cr in March 2025 from 0.49 Cr in March 2024. The company's total assets rose to 11.82 Cr in March 2025 from 11.36 Cr in March 2024, and total liabilities also increased ...

View All News

Announcement

REVISED Outcome Of The Board Meeting

27-Nov-2025 | Source : BSE

Dear Sir Please find the attached REVISED OURCOME OF THE MEETING held on 27-11-2025. Kindly take the note of the same. Director

Appointment of Company Secretary and Compliance Officer

27-Nov-2025 | Source : BSE

Dear Sir Please find the attached below the appointment of Company Secretary and Compliance Officer with effect form 1-12-2025. Kindly update the same at your end and oblige us. Director

Outcome Of The Board Meeting

27-Nov-2025 | Source : BSE

Dear I have submitted the Outcome of Board meeting held on 27-11-2025 without sign hence submitting it again with signature. Kindly consider the same. Director